£34.76

Humana Combination Cancer Therapy: Modulators and Potentiators

Name: Humana Combination Cancer Therapy: Modulators and Potentiators
Brand: Humana
Price: 34.76 GBP
Availability: InStock

Oncology

This is the usual price. Wait for it to drop, or tell us your number.

£35 today · usual range £33–£36 · best ever £33

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 43 days • 43 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 43 days • 4 price levels

Days at Price

Current Price

Price Analysis

Most common price: £33 (14 days, 32.6%)

Price range: £33 - £36

Price levels: 4 different prices over 43 days

Description

Explore the evolving landscape of medical oncology with Combination Cancer Therapy: Modulators and Potentiators. This professional resource provides a deep look into how novel target agents and classic chemotherapies work together to improve patient outcomes. Expert physician-scientists and clinicians evaluate the most promising combinations for the future of cancer treatment. This text covers essential topics including optimal sequencing, pharmacokinetic interactions, and the impact on downstream cellular signals. You will find detailed information on targeted therapies directed at cell surface receptors like EGF-R and HER2, as well as the cell cycle (CDKs), signal transduction events (PKC and NF-kB), and apoptosis (bcl-2). Designed for medical professionals and researchers, the content offers focused insights into specific areas such as ovarian cancer, hematologic diseases, and breast cancer. Whether you are studying drug discovery or looking for data on therapeutic interactions, this volume serves as a detailed guide to the current state of cancer drug development.

Key Features

Expert clinical reviews of novel target agents and classic chemotherapies to identify promising future medical oncology treatments.

Detailed analysis of optimal drug sequencing and pharmacokinetic interactions for effective combination therapies.

In-depth coverage of cell surface receptor targets including EGF-R and HER2 to aid in drug discovery research.

Comprehensive study of signal transduction events and cellular processes such as PKC, NF-kB, and bcl-2 apoptosis.

Specialized sections focusing on specific disease areas including ovarian cancer, breast cancer, and hematologic diseases.

Technical insights into the cell cycle and CDKs to support advanced oncology research and development.

Product Specifications

Brand: Humana
Format: hardcover
ASIN: 1588292002
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 03 December 2004
Listed Since: 28 December 2006

Barcode

No barcode data available

Humana Combination Cancer Therapy: Modulators and Potentiators

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Side Effects of Medical Cancer Therapy: Prevention and Treatment

Cancer Biology and Therapeutics

Cancer Biology and Therapeutics

Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)

Handbook of Research on Advancements in Cancer Therapeutics (Advances in Medical Diagnosis, Treatment, and Care)

Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)

Cancer Chemotherapy 1: Cancer Treatment and Research: 7

Cancer Chemotherapy: Basic Science to the Clinic

Springer Cancer Chemotherapy Volume 36 - Research Series

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Holland-Frei Cancer Medicine - Volume 1 and 2

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Wiley Anticancer Therapeutics - Oncology Drug Design Book

Cancer Cell Chemoresistance And Chemosensitization

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies

Wiley American Cancer Society's Principles of Oncology Textbook

Immunotoxins: 37 (Cancer Treatment and Research, 37)

Cancer Chemotherapy and Selective Drug Development: Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour ... 24–28, 1983: 23 (Developments in Oncology)

Immunotoxins: 37 (Cancer Treatment and Research, 37)

Springer - Signaling Pathways and Molecular Mediators in Metastasis

Academic Press pH-Interfering Agents in Cancer Therapy Vol 10

UICC Manual of Clinical Oncology